Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Institute

Phase 1b study of SM08502 w/hormonal therapy or chemotherapy in subjects with advanced solid tumors

A Phase 1b, Open-Label, Dose-Escalation, Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Orally Administered SM08502 Combined with Hormonal Therapy or Chemotherapy in Subjects with Advanced Solid TumorsĀ 

Disease Types: Solid Tumors

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

A Phase 1b, Open-Label, Dose-Escalation, Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Orally Administered SM08502 Combined with Hormonal Therapy or Chemotherapy in Subjects with Advanced Solid Tumors 

For more information:

https://clinicaltrials.gov/ct2/show/NCT05084859?cond=A+Phase+1b%2C+Open-Label%2C+Dose-Escalation%2C+Dose-Expansion+Study+Evaluating+the+Safety%2C+Pharmacokinetics%2C+and+Efficacy+of+Orally+Administered+SM08502+Combined+with+Hormonal+Therapy+or+Chemotherapy+in+Subjects+with+Advanced+Solid+Tumors&draw=2&rank=1